Human induced pluripotent stem cell (iPSC) has similar functions to embryonic stem cells (ESCs) and are pluripotent stem cells derived from differentiated cells after reprogramming. The iPSC provided by Ubigene is obtained by inducing reprogramming of normal male somatic cells. It has strong differentiation ability and is consistent with the original cell genetic background. Under specific conditions, the cells can re-differentiate into specific cell types or tissues. It can be widely used in disease modeling, drug development and disease cell therapy.
Low passages, high viability and good cell condition
Provide STR authentication report, to ensure the accurate cell identity.
Provides karyotype reports to ensure that the cells are not transformed and malignant.
Strong differentiation ability
Has the potential to differentiate into a variety of cells, such as cardiomyocyte, hepatocyte, nerve cell, etc.
Professional technical support
Ubigene has long been committed to the field of gene editing. With rich gene editing experience, complete gene editing solutions, and the first-class gene editing model animal platform, Ubigene provides you with products, services and free technical consulting to help you with your scientific research in all aspects.
Wide range of applications
Apply in research of endocrine system diseases, cardiovascular diseases, surgical diseases, digestive system diseases, autoimmune system diseases, nervous system diseases, blood system diseases, etc.